MOON101 / Moonlight Therap - LARVOL DELTA

SURVEYOR: Safety of MOON101 for the Treatment of Peanut Allergy (clinicaltrials.gov) - P1 | N=40 | Recruiting | Sponsor: Moonlight Therapeutics, Inc. | Not yet recruiting ➔ Recruiting

Enrollment open • Allergy • Food Hypersensitivity • Immunology

Moonlight Therapeutics Initiates Phase I Clinical Trial (SURVEYOR) of MOON101 for Peanut Allergy (Yahoo Finance) - “Moonlight Therapeutics…announced the initiation of SURVEYOR, a Phase I clinical trial, evaluating MOON101 for the treatment of peanut allergy, marking the program’s transition into clinical-stage development.”

Trial status • Allergy

SURVEYOR: Safety of MOON101 for the Treatment of Peanut Allergy (clinicaltrials.gov) - P1 | N=40 | Not yet recruiting | Sponsor: Moonlight Therapeutics, Inc.

First-in-human • New P1 trial • Allergy • Food Hypersensitivity • Immunology

Moonlight Therapeutics Completes Pre-IND Meeting With the FDA for MOON101 for Peanut Allergy (Moonlight Press Release) - "Moonlight Therapeutics...announced today it successfully completed a pre-Investigational New Drug Application (pre-IND) meeting with the U.S. Food and Drug Administration (FDA) to discuss the regulatory pathway for the development of MOON101 for the treatment of peanut allergy. More specifically, Moonlight has received guidance from the FDA on a first-in-human clinical trial for MOON101 in peanut allergic children and adults....Moonlight expects to submit the IND package for MOON101 to the FDA later this year."

FDA event • IND • Food Hypersensitivity